Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management

被引:340
作者
Eaton, John E. [1 ]
Talwalkar, Jayant A. [1 ]
Lazaridis, Konstantinos N. [1 ]
Gores, Gregory J. [1 ]
Lindor, Keith D. [2 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Mayo Clin Arizona, Div Hepatol, Phoenix, AZ USA
基金
美国国家卫生研究院;
关键词
Cholestatic Liver Disease; Cholangiocarcinoma; Autoimmune Disease; Inflammatory Bowel Disease; DOSE URSODEOXYCHOLIC ACID; INFLAMMATORY-BOWEL-DISEASE; IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS; WIDE ASSOCIATION ANALYSIS; BILIARY EPITHELIAL-CELLS; ULCERATIVE-COLITIS; LIVER-TRANSPLANTATION; NATURAL-HISTORY; RISK-FACTORS; COLORECTAL NEOPLASIA;
D O I
10.1053/j.gastro.2013.06.052
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Primary sclerosing cholangitis (PSC), first described in the mid-1850s, is a complex liver disease that is heterogeneous in its presentation. PSC is characterized by chronic cholestasis associated with chronic inflammation of the biliary epithelium, resulting in multifocal bile duct strictures that can affect the entire biliary tree. Chronic inflammation leads to fibrosis involving the hepatic parenchyma and biliary tree, which can lead to cirrhosis and malignancy. The etiology of PSC is not fully understood, which in part explains the lack of effective medical therapy for this condition. However, we have begun to better understand the molecular pathogenesis of PSC. The recognition of specific clinical subtypes and their pattern of progression could improve phenotypic and genotypic classification of the disease. We review our current understanding of this enigmatic disorder and discuss important topics for future studies.
引用
收藏
页码:521 / 536
页数:16
相关论文
共 169 条
[1]
Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: Evaluating the role of routine magnetic resonance imaging [J].
Abdalian, Rupert ;
Dhar, Preeti ;
Jhaveri, Kartik ;
Haider, Masoom ;
Guindi, Maha ;
Heathcote, E. Jenny .
HEPATOLOGY, 2008, 47 (03) :949-957
[2]
Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation [J].
Adeyi, O. ;
Fischer, S. E. ;
Guindi, M. .
JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (01) :47-74
[3]
Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis [J].
Al Mamari, Said ;
Djordjevic, Jelena ;
Halliday, John S. ;
Chapman, Roger W. .
JOURNAL OF HEPATOLOGY, 2013, 58 (02) :329-334
[4]
Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival [J].
Al-Chalabi, T. ;
Portmann, B. C. ;
Bernal, W. ;
Mcfarlane, I. G. ;
Heneghan, M. A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (02) :209-220
[5]
Comorbidities, Sphincterotomy, and Balloon Dilation Predict Post-ERCP Adverse Events in PSC Patients: Operator Experience Is Protective [J].
Alkhatib, Amer A. ;
Hilden, Kristen ;
Adler, Douglas G. .
DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (12) :3685-3688
[6]
Clinical profile of primary sclerosing cholangitis in Singapore [J].
Ang, TL ;
Fock, KM ;
Ng, TM ;
Teo, EK ;
Chua, TS ;
Tan, JYL .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (08) :908-913
[7]
Small-duct primary sclerosing cholangitis: A long-term follow-up study [J].
Angulo, P ;
Maor-Kendler, Y ;
Lindor, KD .
HEPATOLOGY, 2002, 35 (06) :1494-1500
[8]
Serum autoantibodies in patients with primary sclerosing cholangitis [J].
Angulo, P ;
Peter, JB ;
Gershwin, ME ;
DeSotel, CK ;
Shoenfeld, Y ;
Ahmed, AEE ;
Lindor, KD .
JOURNAL OF HEPATOLOGY, 2000, 32 (02) :182-187
[9]
The immunobiology of primary sclerosing cholangitis [J].
Aron, Jonathan H. ;
Bowlus, Christopher L. .
SEMINARS IN IMMUNOPATHOLOGY, 2009, 31 (03) :383-397
[10]
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community [J].
Bambha, K ;
Kim, WR ;
Talwalkar, J ;
Torgerson, H ;
Benson, JT ;
Therneau, TM ;
Loftus, EV ;
Yawn, BP ;
Dickson, ER ;
Melton, LJ .
GASTROENTEROLOGY, 2003, 125 (05) :1364-1369